Abreva 00135-0300-02
Generic: Docosanol
- Manufacturer
- Haleon Us Holdings Llc
- Dosage Form
- Cream
- Route
- Topical
- Product Type
- Human Otc Drug
- Marketing Start
- March 25, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208754
Active Ingredients
| Ingredient | Strength |
|---|---|
| Docosanol | 100 mg/g |
Selected Package
00135-0300-02Selected2 TUBE in 1 PACKAGE (0135-0300-02) / 2 g in 1 TUBE
Other packages for this product(1)
1 TUBE in 1 PACKAGE (0135-0300-01) / 2 g in 1 TUBE